1/This @thedailybeast piece offers "medication counts" as *the key* to patient safety & health. Taken seriously, it endangers human beings. It deserves condemnation from every clinician who works on opioids, patient safety, pain & patient-centered care. thedailybeast.com/how-the-va-is-…
2/I disavow speaking for any agency. But I do speak for myself, and peers who have dedicated their lives to improving patient safety, as reflected in peer-reviewed lit I will cite. With Jeffrey Samet, who directs one node of the NIH HEAL initiative: jamanetwork.com/journals/jaman…
4/"Opioid Deaths in Ontario Canada" with @DrScottHadland
- we underscore that YES opioid prescribing can be harmful. And YES we must also avoid myopic ways of thinking about complex problems at this time bmj.com/content/362/bm…
5/We now understand that the human response to historic overprescribing patterns and uncritical, unthoughtful media stories of "the prescriptions are high" is incautious reduction, as charted by @HNeprashlink.springer.com/article/10.100…
6/The changes spurred by such reactive coverage are due to health systems that can't handle subtlety, that devalue human contact, and clinicians who are themselves uncomfortable with opioid/pain/addiction issues, as I coauthored with @varley
here: journals.sagepub.com/doi/full/10.11…
7/The normal, ordinary response to that Newsweek article is to intensify and speed up reductions among persons who are long term opioid recipients, i.e. easily flagged targets. Our views of the science and the ethics of that are journals.sagepub.com/doi/abs/10.117…
8/Sum-up: Flooding people with psychoactive Rx treatments is harmful. It reflects our addiction to simplistic solutions.And myopic focus on only "the pills" spurred a contrary rampage, with innocent victims. Just because journalists can exploit that, doesn't mean they should/fin
• • •
Missing some Tweet in this thread? You can try to
force a refresh
1/In 2007, after a wave of >1000 fentanyl overdose deaths, I wrote that the fundamental barrier to saving lives was a reluctance to “speak with outrage, and with love, about the lives that have been lost”
2/I am asking seriously. My thought had been “if we speak now and say these lives matter to us, we will do everything in our power to save them”.
What is the lesson of the last five years? Have our actions been insufficient? Many state policies: jamanetwork.com/journals/jaman…
3/That last paper suggests the success of prescription opioid control just pushed the number of deaths ⬆️ as people with opioid use disorder shifted toward more lethal product. But such state level models are never free of fault.
1/The message from @AmerMedicalAssn to “Stop Scope Creep” flags a signal in opposition to the lessons I gained from 24 years of care for persons experiencing homelessness.
2/I can imagine some specific tensions that do arise for generalist MDs like me if payers supplant us fully in favor of other clinicians - but a broadcast hashtag #StopScopeCreep runs smack into many other competing and serious problems
3/First: in my world of caring for persons experiencing homelessness, I have been teamed up with Nurse Practitioners and Physician Assistants and RNs whose training and life experience are absolutely crucial, and compensate for my limitations
2/Interviews with 41 persons tapered (⬇️>50% ) were open. The framework for assessing stigma allowed that it may include “societal-level conditions, cultural norms, & institutional policies that constrain the opportunities, resources, and wellbeing of the stigmatized”
3/Major finding: "Participants identified themselves as overlooked and negatively impacted by measures implemented during the pharmacovigilance period, including various tapering initiatives"
Yep, I've witnessed that.
1/I'm excited that Dr. @AjayManhapra is presenting on concerns about mandatory opioid taper for VA's MAT-VA journal club, based on our shared paper... he notes Human costs of mandatory and widespread opioid taper
2/He cites @BethDarnall as the best available study, noting that even when one offers the best support system, a significant % of patients do not have a reduction in pain or pain worsens.
3/In a way that will seem controversial, he proposes that opioid therapy is not exactly an analgesic. This is daily use of an addictive substance that offers relief, where only a minority develop addiction.
1/Nice viewpoint out today: "Balancing the Risks and Benefits of Benzodiazepines" -authors note risks of these drugs and their utility, in light of @US_FDA changing the label to highlight risks jamanetwork.com/journals/jama/…
2/FDA's revised warning will more thoroughly cover risks, and the authors endorse that "increased caution regarding benzodiazepine use is warranted; fewer benzodiazepine prescriptions are needed" ... with a careful stipulation...
3/Benzodiazepine risks needed to be highlighted, "However, when considered without an appropriate patient-centered context, this enhanced warning statement might lead to fewer appropriate prescriptions and unintended consequences" - this should echo what happened with opioids